Hesitancies in primary headaches treatments-Reference-Cited by-同舟云学术

Hesitancies in primary headaches treatments

Published:2022-09-01 Issue:9 Volume:22 Page:733-735
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Wells-Gatnik William David¹,Ambat Fidel Dominique Festin¹,Martelletti Paolo¹²^ORCID

Affiliation:

1. Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy

2. Regional Referral Headache Center, Emergency Medicine Unit, Sant’Andrea University Hospital, Rome, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2022.2117613

Reference16 articles.

1. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates

2. Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description

3. Headache service quality evaluation: implementation of quality indicators in primary care in Europe

4. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

5. [cited 2022 Jun 1]. Available from: https://www.ema.europa.eu/en/documents/smop/questions-answers-refusal-change-marketing-authorisation-emgality-galcanezumab_en.pdf

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns and characteristics of headache in patients in Japan: A retrospective cross-sectional and longitudinal analysis of health insurance claims data;Cephalalgia;2024-01

2. Unmet Needs in the Acute Treatment of Migraine;Advances in Therapy;2023-11-09